Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.73 |
| ▸ | MAPT | P10636 | 1/20 | 0.73 |
| ▸ | THRB | P10828 | 1/20 | 0.73 |
| ▸ | CNR1 | P21554 | 1/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.65 |
| ▸ | TSHR | P16473 | 2/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | F7 | P08709 | 4/20 | 0.63 |
| ▸ | F3 | P13726 | 4/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.63 |
| ▸ | PPARG | P37231 | 3/20 | 0.63 |
| ▸ | PPARD | Q03181 | 3/20 | 0.63 |
| ▸ | PPARA | Q07869 | 3/20 | 0.63 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.63 |
| ▸ | FABP3 | P05413 | 2/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.63 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8982650 | 1.00 | MGLL (0.75) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL423106 | 1.00 | MGLL (0.75) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL29562070 | 1.00 | MGLL (0.75) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL23068611 | 1.00 | MGLL (0.75) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL8982652 | 1.00 | MGLL (0.75) | MGLLALDH1A1MAPTTHRBCNR1 | |
| Iodide SCHEMBL28774881 | 0.98 | MGLL (0.73) | MGLLALDH1A1MAPTTHRBCNR1 | |
| Methane SCHEMBL28105583 | 0.98 | MGLL (0.73) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL3660029 | 0.95 | MGLL (0.82) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL7639501 | 0.95 | MGLL (0.77) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL3660027 | 0.95 | MGLL (0.82) | MGLLALDH1A1MAPTTHRBCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075746-A | Microsphere composition, preparation method thereof and application thereof in preparation of contrast agent and medicine | — | 2026-05-26 | — | — | CN | claimed |
| EP-4359531-A1 | METHODS FOR IN VIVO EDITING OF A LIVER GENE | Intellia Therapeutics, Inc. (US) | 2024-05-01 | — | — | EP | claimed |
| EP-4352225-A1 | MODIFIED GUIDE RNAS COMPRISING AN INTERNAL LINKER FOR GENE EDITING | Intellia Therapeutics, Inc. (US) | 2024-04-17 | — | — | EP | claimed |
| WO-2022271780-A1 | METHODS FOR IN VIVO EDITING OF A LIVER GENE | INTELLIA THERAPEUTICS, INC. (US) | 2022-12-29 | — | — | WO | claimed |
| WO-2022261292-A1 | MODIFIED GUIDE RNAS COMPRISING AN INTERNAL LINKER FOR GENE EDITING | INTELLIA THERAPEUTICS, INC. (US) | 2022-12-15 | — | — | WO | claimed |
| US-20210068444-A1 | CANNABINOID COMPOSITIONS WITH IMPROVED ORGANOLEPTIC AND THERAPEUTIC PROPERTIES, METHOD OF PRODUCTION, AND USE THEREOF | CALIFORNIA AMBER INC. | 2021-03-11 | — | — | US | claimed |
| WO-2026102260-A1 | CRISPR-RELATED METHODS AND COMPOSITIONS TARGETING ANGIOPOIETIN LIKE 3 (ANGPTL3) | EDITAS MEDICINE, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| WO-2026102108-A1 | DNA PRODUCTION METHODS | FLAGSHIP PIONEERING INNOVATIONS VII, LLC (US) | 2026-05-15 | — | — | WO | disclosed |
| EP-4655402-A1 | NUCLEIC ACID VACCINES FOR VARICELLA-ZOSTER VIRUS (VZV) | Providence Therapeutics Holdings Inc. (CA) | 2025-12-03 | — | — | EP | disclosed |
| EP-4638748-A2 | COMPOSITIONS AND METHODS FOR PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) EDITING | Intellia Therapeutics, Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| EP-4619438-A2 | COMPOSITIONS AND METHODS FOR FIBROBLAST GROWTH FACTOR RECEPTOR 3-MEDIATED DELIVERY TO ASTROCYTES | Regeneron Pharmaceuticals, Inc. (US) | 2025-09-24 | — | — | EP | disclosed |
| EP-4561636-A1 | COMPOSITIONS AND METHODS FOR TRANSFERRIN RECEPTOR (TFR)-MEDIATED DELIVERY TO THE BRAIN AND MUSCLE | Regeneron Pharmaceuticals, Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| EP-4522726-A1 | VECTORS AND METHODS FOR IN VIVO ANTIBODY PRODUCTION | Regeneron Pharmaceuticals, Inc. (US) | 2025-03-19 | — | — | EP | disclosed |
| EP-4143304-A2 | METHODS OF IN VITRO CELL DELIVERY | Intellia Therapeutics, Inc. (US) | 2023-03-08 | — | — | EP | disclosed |
| CN-115516090-A | TREM compositions and uses thereof | 旗舰先锋创新VI有限责任公司 | 2022-12-23 | — | — | CN | disclosed |
| WO-2022261292-A1 | MODIFIED GUIDE RNAS COMPRISING AN INTERNAL LINKER FOR GENE EDITING | INTELLIA THERAPEUTICS, INC. (US) | 2022-12-15 | — | — | WO | disclosed |
| CN-115362256-A | Compositions and methods for kallikrein (KLKB 1) gene editing | 因特利亚治疗公司 | 2022-11-18 | — | — | CN | disclosed |
| EP-4073249-A1 | MODIFIED GUIDE RNAS FOR GENE EDITING | Intellia Therapeutics, Inc. (US) | 2022-10-19 | — | — | EP | disclosed |
| WO-2021050786-A1 | CANNABIN OID COMPOSITIONS WITH IMPROVED ORGANOLEPTIC AND THERAPEUTIC PROPERTIES, METHOD OF PRODUCTION, AND USE THEREOF | CALIFORNIA AMBER INC. (US) | 2021-03-18 | — | — | WO | disclosed |
| US-20210068444-A1 | CANNABINOID COMPOSITIONS WITH IMPROVED ORGANOLEPTIC AND THERAPEUTIC PROPERTIES, METHOD OF PRODUCTION, AND USE THEREOF | CALIFORNIA AMBER INC. | 2021-03-11 | — | — | US | disclosed |